Finance

Beta
Lists
PTHS:NYSEAMERICAN
Pelthos Therapeutics Inc
$27.50
-4.25%
(-1.22) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTHS...
Open
$26.47
High
$27.55
Low
$26.47
Mkt. cap
95.58M
Avg. vol.
20.23K
Volume
0.00
52-wk high
$54.29
52-wk low
$11.20
EPS
-$20.59
Shares outstanding
3.48M
No. of employees
92
Open
$26.47
High
$27.55
Low
$26.47
Mkt. cap
95.58M
Avg. vol.
20.23K
Volume
0.00
52-wk high
$54.29
52-wk low
$11.20
EPS
-$20.59
Shares outstanding
3.48M
No. of employees
92
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to PTHS in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for PTHS in the last 3 months.
Highest
Current $27.50
$75.00 (+172.73%)
Average
$57.71 (+109.85%)
Lowest
$48.00 (+74.55%)
News stories
From sources across the web
About Pelthos Therapeutics Inc
CEO-
Employees92
Founded2002
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
7.41M
9.39M
10.91M
Cost of goods sold
514.81K
2.46M
2.05M
1.86M
Cost of revenue
514.81K
2.46M
2.05M
1.86M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.72M
19.63M
18.47M
21.10M
Operating expense
2.72M
20.31M
19.35M
22.14M
Total operating expenses
3.23M
22.77M
21.39M
23.99M
Operating income
-3.23M
-15.36M
-12.00M
-13.09M
Other non operating income
-
-
-14.98M
5.20M
EBT including unusual items
-3.45M
-16.70M
-28.59M
-10.24M
EBT excluding unusual items
-3.45M
-16.70M
-28.30M
-10.24M
Income tax expense
-
-465.00K
-6.92M
-
Effective tax rate
-
2.78%
24.21%
-
Other operating expenses
-
-
-
-
Net income
-3.45M
-16.24M
-21.66M
-10.24M
Net profit margin
-
-219.25%
-230.74%
-93.87%
Earnings per share
-5.38
-5.30
-2.69
-4.66
Interest and investment income
-
5.00K
-
-
Interest expense
-218.52K
-1.35M
-1.31M
-2.35M
Net interest expenses
-218.52K
-1.34M
-1.31M
-2.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-15.01M
-10.79M
-11.59M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more